Where is Algorx located?

Algorx is headquartered in Sheridan, United States.

Is Algorx a funded company?

Algorx is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Algorx rank among its competitors?

Algorx ranks 9th amongst 9 active competitors, of which 2 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was eMed, which secured $200M in Mar, 2026.

Who are the top competitors of Algorx?

Algorx's top competitors include eMed, Anja and imaware. Among them, eMed secured the most recent funding round in March, 2026.

Algorx - 2026 Company Profile & Competitors

Company Details

AI based platform offering telemedicine solutions. It provides personalized medication solutions based on the results of diagnostic bloodwork. It leverages artificial intelligence technology to analyze bloodwork data to generate personalized recommendations for enhancing health and well being.

Key Metrics

Location

Sheridan, United States

Stage

Unfunded

Ranked

9^th among 9 active competitors

Similar Companies

eMed & 56 more

View Algorx's full profile

Algorx has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Algorx include eMed, Anja and imaware. Here is the list of Top 10 competitors of Algorx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	eMed 2020, Miami (United States), Series A	Online test management software for employees	$200M	Aon, SV Health Investors & 6 others	57/100
2nd	Anja 2021, Los Angeles (United States), Seed	Provider of cord blood test kits	$5M	Seven Seven Six, Y Combinator & 6 others	40/100
3rd	imaware 2017, Austin (United States), Acquired	Provider of platform for personalized health data and diagnostic testing solutions	-	Plug and Play Tech Center	31/100
4th	MyTabolite 2021, Boston (United States), Unfunded	Software as a service platform that utilizes AI derived algorithms to analyze common blood test results	-	-	24/100
5th	Kazelnut 2022, San Jose (United States), Funding Raised	Developer of a diagnostics device to measure insulin resistance at home	-	Synapses	20/100
6th	Be golden 2021, San Francisco (United States), Deadpooled	Provider of a platform for home blood testing and a digital platform	$500K	Phoenix Investment Club, Y Combinator	20/100
7th	Lola Health 2012, Tampa  Bay (United States), Unfunded	Provider of at-home blood testing and analysis with doctor-reviewed results	-	-	18/100
8th	Ketodoc 2013, Los Angeles (United States), Unfunded	Provider of a ketone and glucose blood meter kit	-	-	16/100
9th	Algorx Sheridan (United States), Unfunded	AI based platform offering telemedicine solutions	-	-	16/100
10th	Bloodscore 2013, Fort Worth (United States), Unfunded	Provider of home-based blood test kits	-	-	16/100